The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus

Author:

Morel Thomas1ORCID,Cano Stefan2,Bartlett Susan J3ORCID,Gordon Caroline4,Haier Birgit5,Regnault Antoine2,Schneider Matthias6,Stach Christian5,Cleanthous Sophie2

Affiliation:

1. UCB Pharma, Brussels, Belgium

2. Modus Outcomes, Letchworth Garden City, UK

3. Department of Medicine, McGill University, Montreal, Quebec, Canada

4. Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK

5. UCB Pharma, Monheim am Rhein

6. Poliklinik und Funktionsbereich für Rheumatologie, Heinrich-Heine-Universität, Düsseldorf, Germany

Abstract

Abstract Objectives This study aimed to implement a patient-centred and evidence-based approach to develop a novel patient-reported outcome (PRO) instrument to measure fatigue in patients with SLE. Methods A three-step mixed methods psychometric (MMP) approach was followed. Steps comprised first draft item generation and review using interview data; evaluation and refinement of second draft items using mixed methods data, including interview and quantitative data from a phase 2 clinical study in SLE analysed using Rasch Measurement Theory (RMT) analysis; and evaluation of the final FATIGUE-PRO items using RMT and complementary Classical Test Theory (CTT) analyses. Guided by MMP criteria, a team of clinicians and outcome-measurement experts assessed evidence to inform instrument development. Results Step 1 culminated in 55 items (n = 39 patients interviewed). Their refinement in step 2 using mixed methods evidence led to the final FATIGUE-PRO instrument comprising 31 items across three scales of fatigue: physical fatigue (9 items), mental and cognitive fatigue (11 items) and susceptibility to fatigue (11 items). Qualitative (n = 43 patients) and quantitative (n = 106 patients) evidence strongly supported the scales’ content comprehensiveness and targeting, item quality and fit, conceptual uniqueness and appropriateness of the response scale. The FATIGUE-PRO further benefited from excellent reliability (RMT: 0.92–0.94 and CTT: 0.95–0.96) and supportive evidence of construct validity from assessments against other PROs. Conclusion The conceptual advances, comprehensive coverage and strong psychometric properties of the FATIGUE-PRO will significantly advance the measurement and management of fatigue in SLE, both in clinical trials and routine practice. Trial registration ClinicalTrials.gov (https://clinicaltrials.gov), NCT02804763

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference40 articles.

1. Management strategies and future directions for systemic lupus erythematosus in adults;Durcan;Lancet,2019

2. What do we know about self-reported fatigue in systemic lupus erythematosus?;Cleanthous;Lupus,2012

3. AB0633 measuring what matters to lupus patients: translating patient views into novel patient-reported outcomes;Cleanthous;Ann Rheum Dis,2018

4. Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: analysis of real-world data;Touma;Arthritis Care Res (Hoboken),2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3